Fledrich, R., R. M. Stassart, A. Klink, L. M. Rasch, T. Prukop, L. Haag, D. Czesnik, T. Kungl, T. A. M. Abdelaal, N. Keric, C. Stadelmann, W. Brück, K.-A. Nave and M. W. Sereda: Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A. In: Nature Medicine 20, 9, 1055-1061 (2014).
Barrantes-Freer, A., E. Kim, J. Bielanska, A. Giese, L. S. Mortensen, W. Schulz-Schaeffer, C. Stadelmann, W. Brück and L. A. Pardo: Human glioma-initiating cells show a distinct immature phenotype resembling but not identical to NG2 glia. In: Journal of Neuropathology and Experimental Neurology 72, 4, 307-324 (2013).
Manrique-Hoyos, N., T. Jürgens, M. Grønborg, M. Kreutzfeldt, M. Schedensack, T. Kuhlmann, C. Schrick, W. Brück, H. Urlaub, M. Simons and D. Merkler: Late motor decline after accomplished remyelination: Impact for progressive multiple sclerosis. In: Annals of Neurology 71, 2, 227-244 (2012).
Merkler, D., F. Klinker, T. Jürgens, R. Glaser, W. Paulus, B. G. Brinkmann, M. W. Sereda, C. Stadelmann-Nessler, R. C. A. Guedes, W. Brück and D. Liebetanz: Propagation of spreading depression inversely correlates with cortical myelin content. In: Annals of Neurology 66, 355-365 (2009).
doi: 10.1002/ana.21746
Klopfleisch, S., D. Merkler, M. Schmitz, S. Klöppner, M. Schedensack, G. Jeserich, H. H. Althaus and W. Brück: Negative impact of statins on oligodendrocytes and myelin formation In Vitro and In Vivo. In: Journal of Neuroscience 28, 50, 13609-13614 (2008).
doi: 10.1523/JNEUROSCI.2765-08.2008
Knoblauch, H., C. Tennstedt, W. Brueck, H. Hammer, T. Vulliamy, I. Dokal, R. Lehmann, F. Hanefeld and S. Tinschert: Two brothers with findings resembling congenital intrauterine infection-like syndrome (pseudo-TORCH syndrome). In: American Journal of Medical Genetics 120A, 2, 261-265 (2003).
doi: 10.1002/ajmg.a.20138
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.